Skip to main content

Table 2 Study Objectives

From: The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial

Primary Objective

Secondary objectives

Change in the LV index measured by echocardiography from baseline to follow-up

Change in functional capacity (NYHA class)

 

All cause mortality

 

Cardiovascular death

 

Hospitalization

 

Revascularization procedures (emergency and elective)

 

Change in B-type natriuretic peptide (BNP) level

 

Change in plasma norepinephrine level

 

Change in serum aldosterone level

 

Change in ejection fraction

 

Change in MI index (wall motion score index)

 

Change in sphericity index

 

Change in mitral inflow index (mitral E/A ratio, mitral deceleration time)

 

Change in tissue Doppler index (mitral Ea)

Back to article page

Trials

ISSN: 1745-6215